Chapter 76 – Endometrial Cancer

[1]  R. Nout.  Post operative radiation therapy in endometrial carcinoma : reducing overtreatment and improving quality of life , 2013 .

[2]  Laetitia Huiart,et al.  Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. , 2011, JAMA.

[3]  Geertruida H de Bock,et al.  Cost effectiveness of laparoscopy versus laparotomy in early stage endometrial cancer: a randomised trial. , 2011, Gynecologic oncology.

[4]  R. Barakat,et al.  Advances in the management of endometrial carcinoma. , 2011, Gynecologic oncology.

[5]  S. Hankinson,et al.  Circulating adiponectin levels and risk of endometrial cancer: the prospective Nurses' Health Study. , 2011, American journal of obstetrics and gynecology.

[6]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[7]  A. Mueck,et al.  Hormonal contraception and risk of endometrial cancer: a systematic review. , 2010, Endocrine-related cancer.

[8]  K. Yoshihara,et al.  Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects. , 2010, Gynecologic oncology.

[9]  F. Clavel-Chapelon,et al.  Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition , 2010, International journal of cancer.

[10]  C. Mantzoros,et al.  Alcohol intake and endometrial cancer risk: a meta-analysis of prospective studies , 2010, British Journal of Cancer.

[11]  S. Chanock,et al.  Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes. , 2010, Carcinogenesis.

[12]  P. Stattin,et al.  Metabolic syndrome and endometrial carcinoma. , 2010, American journal of epidemiology.

[13]  I. Buchan,et al.  Incident cancer burden attributable to excess body mass index in 30 European countries , 2010, International journal of cancer.

[14]  M. Pike,et al.  Long-term Postmenopausal Hormone Therapy and Endometrial Cancer , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[15]  B. Henderson,et al.  Body size, adult BMI gain and endometrial cancer risk: the multiethnic cohort , 2010, International journal of cancer.

[16]  D. Mutch.  The new FIGO staging system for cancers of the vulva, cervix, endometrium and sarcomas , 2009 .

[17]  R. Barakat,et al.  Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  D. Cella,et al.  Quality of life of patients with endometrial cancer undergoing laparoscopic international federation of gynecology and obstetrics staging compared with laparotomy: a Gynecologic Oncology Group study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Bhramar Mukherjee,et al.  Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. , 2009, Gastroenterology.

[20]  R. Fishel,et al.  Current and emerging trends in Lynch syndrome identification in women with endometrial cancer. , 2009, Gynecologic oncology.

[21]  A. Fader,et al.  Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. , 2009, Gynecologic oncology.

[22]  M. McCullough,et al.  Antioxidant vitamins and the risk of endometrial cancer: a dose–response meta-analysis , 2009, Cancer Causes & Control.

[23]  L. Brinton,et al.  Timing of births and endometrial cancer risk in Swedish women , 2009, Cancer Causes & Control.

[24]  V. Torri,et al.  Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. , 2009, Journal of the National Cancer Institute.

[25]  Gretchen L. Gierach,et al.  Physical activity, sedentary behavior, and endometrial cancer risk in the NIH‐AARP Diet and Health Study , 2009, International journal of cancer.

[26]  Carol L. Brown,et al.  Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma? , 2009, Gynecologic oncology.

[27]  C. Sima,et al.  Risk of Endometrial Cancer in Relation to Medical Conditions and Medication Use , 2009, Cancer Epidemiology Biomarkers & Prevention.

[28]  R. Barakat,et al.  Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma. , 2009, Gynecologic oncology.

[29]  D. Cella,et al.  A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study. , 2009, Gynecologic oncology.

[30]  J. Manson,et al.  Physical activity, adiposity, and risk of endometrial cancer , 2009, Cancer Causes & Control.

[31]  C. la Vecchia,et al.  Coffee drinking and endometrial cancer risk: a metaanalysis of observational studies. , 2009, American journal of obstetrics and gynecology.

[32]  P. Peeters,et al.  Physical Activity and Endogenous Sex Hormone Levels in Postmenopausal Women: a Cross-Sectional Study in the Prospect-EPIC Cohort , 2009, Cancer Epidemiology Biomarkers & Prevention.

[33]  M. Parmar,et al.  Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study , 2009, The Lancet.

[34]  M. García-Closas,et al.  Two Estrogen-Related Variants in CYP19A1 and Endometrial Cancer Risk: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium , 2009, Cancer Epidemiology Biomarkers & Prevention.

[35]  M. Bell,et al.  Comparison of outcomes and cost for endometrial cancer staging via traditional laparotomy, standard laparoscopy and robotic techniques. , 2008, Gynecologic oncology.

[36]  L. Murray,et al.  Dietary glycaemic index, glycaemic load and endometrial and ovarian cancer risk: a systematic review and meta-analysis , 2008, British Journal of Cancer.

[37]  J. Chang-Claude,et al.  Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC) , 2008, Endocrine-related cancer.

[38]  Bin Wang,et al.  Cigarette smoking and the risk of endometrial cancer: a meta-analysis. , 2008, The American journal of medicine.

[39]  L. Dennis,et al.  Meta-analysis of intrauterine device use and risk of endometrial cancer. , 2008, Annals of epidemiology.

[40]  C. la Vecchia,et al.  Glycemic index, glycemic load, and cancer risk: a meta-analysis. , 2008, The American journal of clinical nutrition.

[41]  L. Vatten,et al.  Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study , 2008, British Journal of Cancer.

[42]  M. Zwahlen,et al.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.

[43]  M. Thun,et al.  Body Mass and Endometrial Cancer Risk by Hormone Replacement Therapy and Cancer Subtype , 2008, Cancer Epidemiology Biomarkers & Prevention.

[44]  M. McCullough,et al.  Association between dietary fiber and endometrial cancer: a dose-response meta-analysis. , 2007, The American journal of clinical nutrition.

[45]  V. Beral,et al.  Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study , 2007, BMJ : British Medical Journal.

[46]  Marianne,et al.  Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). , 2007, Endocrine-related cancer.

[47]  M. McCullough,et al.  Dietary lipids and endometrial cancer: the current epidemiologic evidence , 2007, Cancer Causes & Control.

[48]  M. McCullough,et al.  Fruits and Vegetables and Endometrial Cancer Risk: A Systematic Literature Review and Meta-Analysis , 2007, Nutrition and cancer.

[49]  V. Beral.  Ovarian cancer and hormone replacement therapy in the Million Women Study , 2007, The Lancet.

[50]  M. Dowsett,et al.  Usual Physical Activity and Endogenous Sex Hormones in Postmenopausal Women: The European Prospective Investigation into Cancer–Norfolk Population Study , 2007, Cancer Epidemiology Biomarkers & Prevention.

[51]  R. Goldbohm,et al.  Alcohol consumption, cigarette smoking, and endometrial cancer risk: results from the Netherlands Cohort Study , 2007, Cancer Causes & Control.

[52]  M. García-Closas,et al.  Reproductive risk factors for endometrial cancer among Polish women , 2007, British Journal of Cancer.

[53]  P. Hartge,et al.  Lifetime Weight History and Endometrial Cancer Risk by Type of Menopausal Hormone Use in the NIH-AARP Diet and Health Study , 2007, Cancer Epidemiology Biomarkers & Prevention.

[54]  C. Friedenreich,et al.  Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition , 2007, Cancer Causes & Control.

[55]  C. Mantzoros,et al.  Diabetes and Risk of Endometrial Cancer: A Population-Based Prospective Cohort Study , 2007, Cancer Epidemiology Biomarkers & Prevention.

[56]  N. Weiss,et al.  Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors. , 2006, American journal of epidemiology.

[57]  R. Barakat,et al.  The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. , 2006, Gynecologic oncology.

[58]  G. Fleming,et al.  Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma , 2006, Cancer.

[59]  J. Cooper,et al.  Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer. , 2006, Gynecologic oncology.

[60]  P. Zola,et al.  Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial , 2006, British Journal of Cancer.

[61]  M. Vessey,et al.  Oral contraceptive use and cancer. Findings in a large cohort study, 1968–2004 , 2006, British Journal of Cancer.

[62]  N. Yaegashi,et al.  Lactation and risk of endometrial cancer in Japan: a case-control study. , 2006, The Tohoku journal of experimental medicine.

[63]  R. Ness,et al.  Inflammation and Endometrial Cancer: A Hypothesis , 2005, Cancer Epidemiology Biomarkers & Prevention.

[64]  G. Fleming,et al.  Rare uterine cancers. , 2005, The Lancet. Oncology.

[65]  M. Sherman,et al.  Impact of hysterectomy on endometrial carcinoma rates in the United States. , 2005, Journal of the National Cancer Institute.

[66]  J. Lubin,et al.  Endometrial Carcinoma Risks among Menopausal Estrogen plus Progestin and Unopposed Estrogen Users in a Cohort of Postmenopausal Women , 2005, Cancer Epidemiology Biomarkers & Prevention.

[67]  F. Bray,et al.  Endometrial Cancer Incidence Trends in Europe: Underlying Determinants and Prospects for Prevention , 2005, Cancer Epidemiology Biomarkers & Prevention.

[68]  C. Ulrich,et al.  Effects of exercise on metabolic risk variables in overweight postmenopausal women: a randomized clinical trial. , 2005, Obesity research.

[69]  R. Bentley,et al.  Phase III randomized trial of doxorubicin + cisplatin versus doxorubicin + 24-h paclitaxel + filgrastim in endometrial carcinoma: a Gynecologic Oncology Group study. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[70]  E. Calle,et al.  Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms , 2004, Nature Reviews Cancer.

[71]  R. Broaddus,et al.  Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[72]  M. Maiman,et al.  A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study , 2004 .

[73]  S. Lax.  Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification , 2004, Virchows Archiv.

[74]  F. Berrino,et al.  Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women , 2004, International journal of cancer.

[75]  F. Berrino,et al.  Prediagnostic levels of C‐peptide, IGF‐I, IGFBP ‐1, ‐2 and ‐3 and risk of endometrial cancer , 2004, International journal of cancer.

[76]  T. Raff,et al.  Use of oral contraceptives and risk of cancer of the uterine corpus or ovary. Two case-control studies , 2003 .

[77]  D. Albanes,et al.  Physical activity and risk of endometrial cancer in a prospective cohort study (United States) , 2003, Cancer Causes & Control.

[78]  A. Furberg,et al.  Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort , 2003, International journal of cancer.

[79]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[80]  H. Adami,et al.  Overweight as an avoidable cause of cancer in Europe , 2001, International journal of cancer.

[81]  H. Brölmann,et al.  The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia , 2000, Cancer.

[82]  F. Larrea,et al.  Case–control study of diabetes, obesity, physical activity and risk of endometrial cancer among Mexican women , 2000, Cancer Causes & Control.

[83]  A. Trentham-Dietz,et al.  Breast feeding practices in relation to endometrial cancer risk, USA , 2000, Cancer Causes & Control.

[84]  P. Koper,et al.  Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial , 2000, The Lancet.

[85]  E. Lazcano-Ponce,et al.  Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico. , 1999, Cancer research.

[86]  P. Newcomb,et al.  Diabetes, body size, and risk of endometrial cancer. , 1998, American journal of epidemiology.

[87]  R. Hoover,et al.  Serum hormone levels in relation to reproductive and lifestyle factors in postmenopausal women (United States) , 1998, Cancer Causes & Control.

[88]  R. Hoover,et al.  Insulin and endometrial cancer. , 1997, American journal of epidemiology.

[89]  J. Eley,et al.  Racial Differences in Endometrial Cancer Survival: The Black/White Cancer Survival Study , 1996, Obstetrics and gynecology.

[90]  R. Hoover,et al.  Case-control study of endogenous steroid hormones and endometrial cancer. , 1996, Journal of the National Cancer Institute.

[91]  M. Sherman,et al.  Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. , 1995, Human pathology.

[92]  M H Skolnick,et al.  Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. , 1994, Journal of the National Cancer Institute.

[93]  L. Kuller,et al.  Black-white differences in serum sex hormones and bone mineral density. , 1994, American journal of epidemiology.

[94]  A. L. Nielsen,et al.  Endometrial cancer in postmenopausal women with and without previous estrogen replacement treatment: comparison of clinical and histopathological characteristics. , 1993, Gynecologic oncology.

[95]  K. Hatch,et al.  Endometrial cancer, obesity, and body fat distribution. , 1991, Cancer research.

[96]  R. Pokras,et al.  Hysterectomy in the United States, 1965-84. , 1988, American journal of public health.

[97]  M. Pike,et al.  The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. , 1988, British Journal of Cancer.

[98]  B. Bundy,et al.  Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study , 1987, Cancer.

[99]  P. Oefner,et al.  Cryptorchidism and fertility , 1986, World Journal of Urology.

[100]  A. Feinstein,et al.  Estrogens and endometrial cancer. Responses to arguments and current status of an epidemiologic controversy. , 1986, The American journal of medicine.

[101]  J. V. Bokhman.  Two pathogenetic types of endometrial carcinoma. , 1983, Gynecologic oncology.

[102]  R. Kurman,et al.  Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well‐differentiated carcinoma , 1982, Cancer.

[103]  P. Kraft,et al.  Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the Nurses' Health Study cohort 1976–2004 , 2010, International journal of cancer.

[104]  J. Chang-Claude,et al.  Physical activity and endogenous sex hormones in postmenopausal women: to what extent are observed associations confounded or modified by BMI? , 2010, Cancer Causes & Control.

[105]  Nobuyuki Susumu,et al.  Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. , 2008, Gynecologic oncology.

[106]  C. Friedenreich,et al.  Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women. , 2007, The Journal of clinical endocrinology and metabolism.

[107]  R. Broaddus,et al.  Pathologic features of endometrial carcinoma associated with HNPCC , 2006, Cancer.

[108]  J. Thigpen,et al.  Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[109]  R. Kaaks,et al.  Obesity , Endogenous Hormones , and Endometrial Cancer Risk : A Synthetic Review 1 , 2002 .

[110]  B. Ottesen,et al.  Risk factors among young women with endometrial cancer: a Danish case-control study. , 2000, American journal of obstetrics and gynecology.